Fig. 1From: hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stagesAlternation of autoantibody levels in MRL/lpr mice at early stage of disease. A. Procedure timeline. B. Plasma levels of anti-ds DNA antibodies (a) and Antinuclear Antibodies (ANA) (b) in 6-week-old MRL/lpr mice showed a significant increase compared to the MRL/MPJ mice. **P < 0.01; ***P < 0.001. The number of mice is n = 5Back to article page